(Q42014580)

15 October 2017

Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors (English)

1 reference

15 October 2017

0 references

0 references

0 references

S J MacLennan

1 reference

15 October 2017

P H Reynen

series ordinal

1 reference

15 October 2017

J Kwan

series ordinal

1 reference

15 October 2017

D W Bonhaus

series ordinal

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

British Journal of Pharmacology

15 October 2017

1 reference

15 October 2017

124

1 reference

15 October 2017

1 reference

15 October 2017

619-622

1 reference

Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder

15 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701915

Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701915

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701915

7 January 2021

Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701915

7 January 2021

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701915

7 January 2021

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701915

7 January 2021

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701915

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701915

7 January 2021

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701915

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701915

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

9690851

1 reference